Marking a significant step forward in launching Minnesota’s adult-use cannabis market, the state’s Office of Cannabis Management (OCM) began accepting applications for cannabis business licenses on February 18, 2025. The...more
In part five of our cannabis law series “Saul Sessions," Saul Ewing partners Jonathan Havens and Kayleigh Keilty discuss emerging industry developments and common issues that cannabis businesses face today. This session...more
In part four of our cannabis law series “Saul Sessions," Saul Ewing partners Jonathan Havens and Adam Fayne discuss emerging industry developments and common issues that cannabis businesses face today. This session covers...more
In part 2 of our cannabis law series “Saul Sessions," Saul Ewing partners Jonathan Havens and Brian Landry discuss emerging industry developments and common issues that cannabis businesses face today. This session covers...more
In part 1 of our cannabis law series “Saul Sessions," Jonathan Havens and Adam Fayne from Saul Ewing’s Cannabis Law practice discuss emerging industry developments and common issues that cannabis businesses face today. This...more
Happy 2024! The entire Saul Ewing Health Law Practice Group wishes you and yours a healthy and prosperous new year and successful (and compliant) activities in the health care delivery system this year and beyond....more
2/2/2024
/ Ambulatory Surgery Centers ,
Artificial Intelligence ,
Assisted Living Facilities (ALFs) ,
Centers for Medicare & Medicaid Services (CMS) ,
Controlled Substances Act ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare Facilities ,
HIPAA Violations ,
Hospitals ,
Information Technology ,
Marijuana ,
Medicare ,
Nursing Homes ,
OCR ,
Patient Privacy Rights ,
Pharmaceutical Patents ,
Popular ,
Price Transparency ,
Private Equity ,
Telehealth
Maryland voters overwhelmingly approved Question 4, a ballot measure to legalize adult-use cannabis, on November 8, 2022. The Cannabis Reform Act ‒ which was signed into law by Governor Wes Moore on May 3, 2023 and went into...more
As the cannabis industry continues to grow and expand at a rapid pace, successful operators could become the targets of labeling class actions that have plagued the traditional food and beverage industry for decades,...more
In this episode of "Don't Miss a Beet," host Jonathan Havens, co-chair of Saul Ewing’s Cannabis Law Practice and Food, Beverage and Agribusiness (FBA) Practice, speaks with Ken VandeVrede, CEO of Hillview, a New Jersey-based...more
Long-shot bill would also allow states to set own laws, make FDA lead regulator, address impact of War on Drugs, impose excise tax, and create CBD dietary supplement pathway. More than five months after first previewing...more
On Monday, April 12, 2021, New Jersey’s newly formed and seated Cannabis Regulatory Commission (“CRC” or “the Commission”) — the body that will oversee New Jersey’s medical and adult-use cannabis programs — held its first...more
Although it took much longer than expected following New Jersey’s November 2020 vote to legalize adult-use marijuana, Governor Phil Murphy finally yesterday signed several cannabis reform bills into law, including Assembly...more
On December 18, 2020, just three days after the U.S. Senate adopted the Cannabidiol and Marihuana Research Expansion Act (CMREA or the Act) (more on this below), the U.S. Drug Enforcement Administration (DEA or the...more
The clear winner after the November 3 election was marijuana. In four states – New Jersey, Arizona, South Dakota and Montana – voters approved initiatives to legalize recreational marijuana. South Dakota and Mississippi also...more
On August 21, 2020, nearly two years after the passage of the Agriculture Improvement Act of 2018 (2018 Farm Bill), the Drug Enforcement Administration (DEA or the Agency) published an interim final rule that, according to...more
Overview -
This week, Pennsylvania Senators Daylin Leach (D-Montgomery/Delaware) and Sharif Street (D-Philadelphia) introduced a bill, the “Adult-Use Cannabis Act” (Senate Bill 350), that would legalize adult-use (i.e.,...more
On September 25, 2019, the U.S. House of Representatives overwhelmingly passed the Secure And Fair Enforcement (SAFE) Banking Act (SAFE Act) by vote of 321 to 103. ...more
On July 1, 2019, the New Jersey Department of Health (NJDOH) issued a new Notice of Request for Applications (Notice), replacing the previous Notice that the NJDOH had issued last month, and announced that it is seeking new...more
On June 3, 2019, the New Jersey Department of Health (NJDOH) issued a much-anticipated Notice of Request for Applications (Notice) and announced that it is seeking new applicants to operate up to 108 new medical marijuana...more
On May 2, 2019, the U.S. Patent and Trademark Office (USPTO) issued "Examination Guide 1-19 - Examination of Marks for Cannabis and Cannabis Related Goods and Services after Enactment of the 2018 Farm Bill" (Guidance),...more
On April 2, 2019, outgoing U.S. Food and Drug Administration (FDA or the Agency) Commissioner Scott Gottlieb, M.D., further addressed FDA’s approach to cannabis-containing and cannabis-derived products (e.g., cannabidiol...more
Despite the cold temperatures across much of the country, federal and state food policy, regulations, and enforcement developments have been heating up....more
On December 20, 2018, President Trump signed into law the Agriculture Improvement Act of 2018 (the 2018 Farm Bill). Among other things, the 2018 Farm Bill removes hemp from the definition of "marihuana" (marijuana) in the...more
On November 26, 2018, the New Jersey legislature advanced three cannabis-related bills out of committee; the measures now go to the floor of each chamber, and votes could occur as early as December 17, 2018....more
The U.S. Drug Enforcement Administration (DEA) is expected to publish in the September 28, 2018 edition of the Federal Register an order scheduling U.S. Food and Drug Administration (FDA or the Agency)-approved drugs that...more